5vra
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==2.35-Angstrom In situ Mylar structure of human A2A adenosine receptor at 100 K== | |
| - | + | <StructureSection load='5vra' size='340' side='right' caption='[[5vra]], [[Resolution|resolution]] 2.35Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[5vra]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5VRA OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5VRA FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=OLA:OLEIC+ACID'>OLA</scene>, <scene name='pdbligand=OLB:(2S)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLB</scene>, <scene name='pdbligand=OLC:(2R)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene>, <scene name='pdbligand=ZMA:4-{2-[(7-AMINO-2-FURAN-2-YL[1,2,4]TRIAZOLO[1,5-A][1,3,5]TRIAZIN-5-YL)AMINO]ETHYL}PHENOL'>ZMA</scene></td></tr> | |
| - | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5vra FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5vra OCA], [http://pdbe.org/5vra PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5vra RCSB], [http://www.ebi.ac.uk/pdbsum/5vra PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5vra ProSAT]</span></td></tr> |
| + | </table> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/AA2AR_HUMAN AA2AR_HUMAN]] Receptor for adenosine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Broecker, J]] | ||
| + | [[Category: Cherezov, V]] | ||
| + | [[Category: Ernst, O P]] | ||
| + | [[Category: Ishchenko, A]] | ||
| + | [[Category: Kissick, D J]] | ||
| + | [[Category: Klingel, V]] | ||
| + | [[Category: Kuo, A]] | ||
| + | [[Category: Lee, M Y]] | ||
| + | [[Category: Makarov, O]] | ||
| + | [[Category: Morizumi, T]] | ||
| + | [[Category: Ogata, C M]] | ||
| + | [[Category: Ou, W L]] | ||
| + | [[Category: Xu, S]] | ||
| + | [[Category: Fusion protein]] | ||
| + | [[Category: Gpcr]] | ||
| + | [[Category: In situ]] | ||
| + | [[Category: Lcp]] | ||
| + | [[Category: Signaling protein]] | ||
Revision as of 06:57, 13 December 2017
2.35-Angstrom In situ Mylar structure of human A2A adenosine receptor at 100 K
| |||||||||||
Categories: Broecker, J | Cherezov, V | Ernst, O P | Ishchenko, A | Kissick, D J | Klingel, V | Kuo, A | Lee, M Y | Makarov, O | Morizumi, T | Ogata, C M | Ou, W L | Xu, S | Fusion protein | Gpcr | In situ | Lcp | Signaling protein
